Mission Hills Financial Advisory LLC grew its holdings in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI – Free Report) by 14.3% in the fourth quarter, HoldingsChannel.com reports. The fund owned 36,111 shares of the exchange traded fund’s stock after acquiring an additional 4,531 shares during the quarter. SPDR S&P Biotech ETF accounts for 2.5% of Mission Hills Financial Advisory LLC’s holdings, making the stock its 16th biggest position. Mission Hills Financial Advisory LLC’s holdings in SPDR S&P Biotech ETF were worth $3,252,000 as of its most recent filing with the Securities and Exchange Commission.
Several other hedge funds have also recently made changes to their positions in XBI. Tidemark LLC increased its stake in shares of SPDR S&P Biotech ETF by 101.5% in the 3rd quarter. Tidemark LLC now owns 395 shares of the exchange traded fund’s stock valued at $39,000 after acquiring an additional 199 shares in the last quarter. Quintet Private Bank Europe S.A. acquired a new stake in SPDR S&P Biotech ETF in the third quarter worth $40,000. ORG Wealth Partners LLC acquired a new stake in SPDR S&P Biotech ETF in the third quarter worth $44,000. Howe & Rusling Inc. bought a new stake in SPDR S&P Biotech ETF in the third quarter valued at $49,000. Finally, Waldron Private Wealth LLC acquired a new position in shares of SPDR S&P Biotech ETF during the third quarter valued at about $54,000.
SPDR S&P Biotech ETF Stock Up 0.1 %
NYSEARCA XBI opened at $87.97 on Friday. SPDR S&P Biotech ETF has a 52 week low of $81.14 and a 52 week high of $105.47. The business has a 50 day moving average price of $94.09 and a 200-day moving average price of $96.94. The company has a market cap of $6.71 billion, a price-to-earnings ratio of 11.47 and a beta of 1.11.
About SPDR S&P Biotech ETF
SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.
See Also
- Five stocks we like better than SPDR S&P Biotech ETF
- Biggest Stock Losers – Today’s Biggest Percentage Decliners
- Earn High Dividends With 2 Top REITs Set to Perform in 2025
- What is a SEC Filing?
- Oilfield Leader SLB: An AI Name You Need to Know
- There Are Different Types of Stock To Invest In
- Top ETFs That Beat the Market in 2024 and Could Do It Again
Want to see what other hedge funds are holding XBI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for SPDR S&P Biotech ETF (NYSEARCA:XBI – Free Report).
Receive News & Ratings for SPDR S&P Biotech ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SPDR S&P Biotech ETF and related companies with MarketBeat.com's FREE daily email newsletter.